H. C. Neu

2.3k total citations
70 papers, 1.9k citations indexed

About

H. C. Neu is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, H. C. Neu has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 43 papers in Molecular Medicine and 23 papers in Infectious Diseases. Recurrent topics in H. C. Neu's work include Antibiotics Pharmacokinetics and Efficacy (46 papers), Antibiotic Resistance in Bacteria (43 papers) and Antimicrobial Resistance in Staphylococcus (19 papers). H. C. Neu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (46 papers), Antibiotic Resistance in Bacteria (43 papers) and Antimicrobial Resistance in Staphylococcus (19 papers). H. C. Neu collaborates with scholars based in United States, Canada and United Kingdom. H. C. Neu's co-authors include N X Chin, P Labthavikul, Brian E. Scully, R. N. Grüneberg, Kwung P. Fu, A.P.R. Wilson, Frank E. Stinchfield, Thomas P. Goss, Louis U. Bigliani and Takuya Kamimura and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bone and Joint Surgery and CHEST Journal.

In The Last Decade

H. C. Neu

66 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. C. Neu United States	26	1.0k	682	552	437	311	70	1.9k
D. S. Reeves United Kingdom	25	680 0.7×	480 0.7×	438 0.8×	328 0.8×	287 0.9×	94	1.8k
D. S. Reeves United Kingdom	26	699 0.7×	457 0.7×	668 1.2×	372 0.9×	280 0.9×	89	1.8k
N X Chin United States	28	1.4k 1.3×	979 1.4×	759 1.4×	633 1.4×	412 1.3×	62	2.3k
Burt R. Meyers United States	27	732 0.7×	453 0.7×	750 1.4×	671 1.5×	193 0.6×	78	2.0k
Marie-Dominique Kitzis France	19	683 0.7×	799 1.2×	523 0.9×	411 0.9×	305 1.0×	48	1.5k
William L. Hewitt United States	23	1.1k 1.1×	622 0.9×	516 0.9×	345 0.8×	186 0.6×	66	1.9k
C H Nightingale United States	26	1.2k 1.2×	576 0.8×	962 1.7×	660 1.5×	178 0.6×	70	2.3k
J. Blaser Switzerland	21	995 1.0×	654 1.0×	544 1.0×	363 0.8×	156 0.5×	51	1.6k
P. M. Waterworth United Kingdom	27	679 0.7×	453 0.7×	496 0.9×	510 1.2×	300 1.0×	66	1.9k
L. Verbist Belgium	29	1.1k 1.1×	686 1.0×	1.0k 1.9×	894 2.0×	304 1.0×	127	2.7k

Countries citing papers authored by H. C. Neu

Since Specialization

Citations

This map shows the geographic impact of H. C. Neu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Neu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Neu more than expected).

Fields of papers citing papers by H. C. Neu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Neu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Neu. The network helps show where H. C. Neu may publish in the future.

Co-authorship network of co-authors of H. C. Neu

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. Neu. A scholar is included among the top collaborators of H. C. Neu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. Neu. H. C. Neu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neu, H. C.. (2015). Microbiology of Bacterial Meningitis Pathogens. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 45. 52–67.

Pechère, J C, et al.. (1995). Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. Journal of Antimicrobial Chemotherapy. 36(5). 757–771. 24 indexed citations

Wilson, A.P.R., R. N. Grüneberg, & H. C. Neu. (1994). A critical review of the dosage of teicoplanin in Europe and the USA. International Journal of Antimicrobial Agents. 4. 1–30. 90 indexed citations

Neu, H. C., et al.. (1993). Efficacy and Safety of Clarithromycin Compared to Cefixime as Outpatient Treatment of Lower Respiratory Tract Infections. CHEST Journal. 104(5). 1393–1399. 35 indexed citations

Wilson, A.P.R., R. N. Grüneberg, & H. C. Neu. (1993). Dosage recommendations for teicoplanin. Journal of Antimicrobial Chemotherapy. 32(6). 792–796. 45 indexed citations

Neu, H. C.. (1992). Can Fluoroquinolones Be Considered Once‐Daily Therapy?. The Journal of Clinical Pharmacology. 32(8). 692–697. 4 indexed citations

Yu, Kwok‐Woon, et al.. (1991). Antibacterial activity of rokitamycin compared with that of other macrolides. Diagnostic Microbiology and Infectious Disease. 14(4). 331–335. 3 indexed citations

Scully, Brian E., et al.. (1991). Oral ofloxacin therapy of infections due to multiply-resistant bacteria. Diagnostic Microbiology and Infectious Disease. 14(5). 435–441. 5 indexed citations

Chin, Nai‐Xun & H. C. Neu. (1991). In vitro activity of LY264826 compared to other glycopeptides and daptomycin. Diagnostic Microbiology and Infectious Disease. 14(2). 181–184. 6 indexed citations

10.

Neu, H. C., et al.. (1991). Fleroxacin combined with rifampin. Diagnostic Microbiology and Infectious Disease. 14(1). 23–27. 6 indexed citations

11.

Neu, H. C.. (1990). Aztreonam activity, pharmacology, and clinical uses. The American Journal of Medicine. 88(3). S2–S6. 29 indexed citations

12.

Neu, H. C.. (1990). Pathophysiologic basis for the use of third-generation cephalosporins. The American Journal of Medicine. 88(4). S3–S11. 23 indexed citations

13.

Neu, H. C.. (1990). Fosfomycin Trometamol versus Amoxycillin – Single-Dose Multicenter Study of Urinary Tract Infections. Chemotherapy. 36(1). 19–23. 25 indexed citations

14.

Yu, Kwok‐Woon & H. C. Neu. (1989). Antibacterial activity and beta-lactamase stability of MDL 19,592, an oral cephalosporin. Diagnostic Microbiology and Infectious Disease. 12(5). 441–443. 1 indexed citations

15.

Neu, H. C.. (1989). New oral and parenteral quinolones. The American Journal of Medicine. 87(5). S283–S287. 12 indexed citations

16.

Neu, H. C.. (1988). Macrolides: Problems and Promises. The Journal of Clinical Pharmacology. 28(2). 153–155. 2 indexed citations

17.

Neu, H. C.. (1988). Cephalosporin antibiotics: Molecules that respond to different needs. The American Journal of Surgery. 155(5). 1–4. 4 indexed citations

18.

Neu, H. C.. (1979). Cefoxitin: An Overview of Clinical Studies in the United States. Clinical Infectious Diseases. 1(1). 233–239. 16 indexed citations

19.

Neu, H. C.. (1979). Comparative Studies of Cefoxitin and Cephalothin: An Overview. Clinical Infectious Diseases. 1(1). 144–150. 16 indexed citations

20.

Williams, John D., A. M. Geddes, & H. C. Neu. (1978). Cefoxitin: microbiology, pharmacology and clinical use.. Journal of Antimicrobial Chemotherapy. 4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact